Literature DB >> 6275931

Hexose transport in Epstein-Barr virus (EBV) negative lymphoma lines and their EBV converted, virus genome carrying sublines.

W Siegert, T Mönch.   

Abstract

Increased hexose uptake is a marker for viral transformation, as has been shown in non-human fibroblasts transformed by oncogenic viruses. If this phenomenon is a general expression of viral induced transformation it should also apply on different oncogenic virus-cell systems. Recently two human EBV-negative lymphoma lines were converted to a stable EBV-positive state by infection with EBV. According to their biochemical and biological properties they enable us to study events associated with EBV-transformation. We analysed the uptake of (3H) glucosamine and (3H) 2-deoxy-D-glucose into BJAB and Ramos and their EBV-converted sublines and found a clear increase of the rate of uptake of both sugars in the EBV-positive sublines. Control experiments confirmed that the increased uptake was due to alterations on the level of the hexose membrane carriers and not due to increased metabolism. The observation of increased hexose uptake in the only presented available virus transformed human cell system is a strong argument for the general importance of this transformation-associated membrane change.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6275931     DOI: 10.1007/bf00320953

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  35 in total

1.  Transformation of primate and rodent cells by temperature-sensitive mutants of SV40.

Authors:  J S Butel; J S Brugge; C A Noonan
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

2.  Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma.

Authors:  J Menezes; W Leibold; G Klein; G Clements
Journal:  Biomedicine       Date:  1975-07

3.  Establishment of EBNA-expressing cell lines by infection of Epstein-Barr virus (EBV)-genome-negative human lymphoma cells with different EBV strains.

Authors:  K O Fresen; H Hausen
Journal:  Int J Cancer       Date:  1976-02-15       Impact factor: 7.396

4.  Activation of the alternative complement pathway by human B cell lymphoma lines is associated with Epstein-Barr virus transformation of the cells.

Authors:  I McConnell; G Klein; T F Lint; P J Lachmann
Journal:  Eur J Immunol       Date:  1978-07       Impact factor: 5.532

5.  Characteristic chromosomal abnormalities in biopsies and lymphoid-cell lines from patients with Burkitt and non-Burkitt lymphomas.

Authors:  L Zech; U Haglund; K Nilsson; G Klein
Journal:  Int J Cancer       Date:  1976-01-15       Impact factor: 7.396

6.  Antibody-induced redistribution of normal and tumor associated surface antigens.

Authors:  E Yefenof; G Klein
Journal:  Exp Cell Res       Date:  1974-10       Impact factor: 3.905

7.  Induction of sugar uptake by a hamster pseudotype sarcoma virus.

Authors:  M Hatanaka; R V Gilden; G Kelloff
Journal:  Virology       Date:  1971-03       Impact factor: 3.616

8.  Cell surface glycoprotein patterns of two EBV-negative lines and their EBV converted sublines.

Authors:  N Koide; A Wells; G Klein; I Ernberg
Journal:  Intervirology       Date:  1981       Impact factor: 1.763

9.  Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas.

Authors:  G Klein; T Lindahl; M Jondal; W Leibold; J Menézes; K Nilsson; C Sundström
Journal:  Proc Natl Acad Sci U S A       Date:  1974-08       Impact factor: 11.205

10.  Epstein-Barr virus-induced increase in the concanavalin-A receptor density of established EBV-negative lymphoma lines in vitro.

Authors:  W Siegert; T Mönch; G Valet
Journal:  Exp Hematol       Date:  1980-11       Impact factor: 3.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.